-
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method.
Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:21-5. -
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH.
Prenat Diagn 2011;31:802-8. -
Fetal RHD Genotyping in Maternal Plasma at 11-13 Weeks of Gestation.
Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
Fetal Diagn Ther 2011;29:301-6. -
Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:819-23. -
Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1550-6. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity.
Scheier M, Hernandez-Andrade E, Carmo A, Dezerega V, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:432-6. -
Predicting the severity of fetal anemia using time-domain measurement of volume flow in the fetal aorta.
Harrington K, Fayyad A, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:437-41. -
Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes.
Patel RK, Nicolaides K, Mijovic A.
Transfusion 2003;43:119-20. -
Fetal bone metabolism in normal and rhesus isoimmunised pregnancies.
Ogueh O, Wright EM, Jones J, Alaghband-Zadeh J, Nicolaides KH, Johnson MR.
BJOG 2001;108:986-92. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization.
Hecher K, Snijders R, Campbell S, Nicolaides KH.
Obstet Gynecol 1995;85:122-8. -
Serum ferritin and cobalamin in red blood cell isoimmunisation.
Abbas A, Nicolaides KH.
Fetal Diagn Ther 1995;10:297-300.